Related Experiment Videos
CD8-suppressor factor and beta-chemokine function as a complementary mechanism to cognate immunity
1Department of Immunology, United Medical, School of Guy's Hospital, London, UK. t.lehner@umds.ac.uk
Immunology Letters
|April 15, 1999
Summary
Immune responses involving CD8-suppressor factors and beta-chemokines correlate with protection against SIV infection. These factors inhibit viral replication by preventing virus binding to cell receptors.
Area of Science:
- Immunology
- Virology
- Vaccinology
Background:
- Protection against Simian Immunodeficiency Virus (SIV) and Human Immunodeficiency Virus (HIV) typically relies on antibody and T-cell responses.
- A complementary protective mechanism involving CD8-suppressor factors (CD8-SF) and beta-chemokines may also be crucial.
- These factors potentially inhibit viral binding and replication.
Purpose of the Study:
- To investigate the role of CD8-SF and beta-chemokines in SIV protection.
- To determine the correlation between specific immunisation methods and protective immune responses.
- To understand the mechanism of SIV replication inhibition by these factors.
Main Methods:
- Targeted iliac lymph node (TILN) immunisation with SIVgp120 and p27.
- Xenoimmunisation with SIV grown in human T-cells.
- Measurement of CD8-SF, RANTES, MIP-1alpha, and MIP-1beta levels.
- In vitro assessment of SIV replication inhibition based on chemokine concentration.
Main Results:
- Immunisation generated CD8-SF, RANTES, MIP-1alpha, and MIP-1beta.
- These factors significantly correlated with protection against SIV infection via rectal mucosal or intravenous routes.
- In vitro SIV replication inhibition was dependent on beta-chemokine concentration, with higher levels needed for rectal mucosal challenge.
- The critical level for inhibition was higher for rectal mucosal than intravenous SIV challenge.
Conclusions:
- CD8-SF and beta-chemokines play a significant role in SIV protection, complementing traditional immune responses.
- The concentration of beta-chemokines generated by immunisation is critical for inhibiting SIV replication.
- The likely in vivo mechanism involves beta-chemokines binding to and causing the internalisation of CCR5 coreceptors, thus blocking SIV entry.